Cargando…
Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome
Pediatric obesity-related metabolic syndrome (MetS) and nonalcoholic fatty liver disease (NAFLD) are increasingly frequent conditions with a still-elusive diagnosis and low-efficacy treatment and monitoring options. In this study, we investigated the salivary metabolomic signature, which has been un...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412994/ https://www.ncbi.nlm.nih.gov/pubmed/30691143 http://dx.doi.org/10.3390/nu11020274 |
_version_ | 1783402735374172160 |
---|---|
author | Troisi, Jacopo Belmonte, Federica Bisogno, Antonella Pierri, Luca Colucci, Angelo Scala, Giovanni Cavallo, Pierpaolo Mandato, Claudia Di Nuzzi, Antonella Di Michele, Laura Delli Bovi, Anna Pia Guercio Nuzio, Salvatore Vajro, Pietro |
author_facet | Troisi, Jacopo Belmonte, Federica Bisogno, Antonella Pierri, Luca Colucci, Angelo Scala, Giovanni Cavallo, Pierpaolo Mandato, Claudia Di Nuzzi, Antonella Di Michele, Laura Delli Bovi, Anna Pia Guercio Nuzio, Salvatore Vajro, Pietro |
author_sort | Troisi, Jacopo |
collection | PubMed |
description | Pediatric obesity-related metabolic syndrome (MetS) and nonalcoholic fatty liver disease (NAFLD) are increasingly frequent conditions with a still-elusive diagnosis and low-efficacy treatment and monitoring options. In this study, we investigated the salivary metabolomic signature, which has been uncharacterized to date. In this pilot-nested case-control study over a transversal design, 41 subjects (23 obese patients and 18 normal weight (NW) healthy controls), characterized based on medical history, clinical, anthropometric, and laboratory data, were recruited. Liver involvement, defined according to ultrasonographic liver brightness, allowed for the allocation of the patients into four groups: obese with hepatic steatosis ([St+], n = 15) and without hepatic steatosis ([St–], n = 8), and with (n = 10) and without (n = 13) MetS. A partial least squares discriminant analysis (PLS-DA) model was devised to classify the patients’ classes based on their salivary metabolomic signature. Pediatric obesity and its related liver disease and metabolic syndrome appear to have distinct salivary metabolomic signatures. The difference is notable in metabolites involved in energy, amino and organic acid metabolism, as well as in intestinal bacteria metabolism, possibly reflecting diet, fatty acid synthase pathways, and the strict interaction between microbiota and intestinal mucins. This information expands the current understanding of NAFLD pathogenesis, potentially translating into better targeted monitoring and/or treatment strategies in the future. |
format | Online Article Text |
id | pubmed-6412994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64129942019-04-09 Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome Troisi, Jacopo Belmonte, Federica Bisogno, Antonella Pierri, Luca Colucci, Angelo Scala, Giovanni Cavallo, Pierpaolo Mandato, Claudia Di Nuzzi, Antonella Di Michele, Laura Delli Bovi, Anna Pia Guercio Nuzio, Salvatore Vajro, Pietro Nutrients Article Pediatric obesity-related metabolic syndrome (MetS) and nonalcoholic fatty liver disease (NAFLD) are increasingly frequent conditions with a still-elusive diagnosis and low-efficacy treatment and monitoring options. In this study, we investigated the salivary metabolomic signature, which has been uncharacterized to date. In this pilot-nested case-control study over a transversal design, 41 subjects (23 obese patients and 18 normal weight (NW) healthy controls), characterized based on medical history, clinical, anthropometric, and laboratory data, were recruited. Liver involvement, defined according to ultrasonographic liver brightness, allowed for the allocation of the patients into four groups: obese with hepatic steatosis ([St+], n = 15) and without hepatic steatosis ([St–], n = 8), and with (n = 10) and without (n = 13) MetS. A partial least squares discriminant analysis (PLS-DA) model was devised to classify the patients’ classes based on their salivary metabolomic signature. Pediatric obesity and its related liver disease and metabolic syndrome appear to have distinct salivary metabolomic signatures. The difference is notable in metabolites involved in energy, amino and organic acid metabolism, as well as in intestinal bacteria metabolism, possibly reflecting diet, fatty acid synthase pathways, and the strict interaction between microbiota and intestinal mucins. This information expands the current understanding of NAFLD pathogenesis, potentially translating into better targeted monitoring and/or treatment strategies in the future. MDPI 2019-01-26 /pmc/articles/PMC6412994/ /pubmed/30691143 http://dx.doi.org/10.3390/nu11020274 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Troisi, Jacopo Belmonte, Federica Bisogno, Antonella Pierri, Luca Colucci, Angelo Scala, Giovanni Cavallo, Pierpaolo Mandato, Claudia Di Nuzzi, Antonella Di Michele, Laura Delli Bovi, Anna Pia Guercio Nuzio, Salvatore Vajro, Pietro Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome |
title | Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome |
title_full | Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome |
title_fullStr | Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome |
title_full_unstemmed | Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome |
title_short | Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome |
title_sort | metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412994/ https://www.ncbi.nlm.nih.gov/pubmed/30691143 http://dx.doi.org/10.3390/nu11020274 |
work_keys_str_mv | AT troisijacopo metabolomicsalivarysignatureofpediatricobesityrelatedliverdiseaseandmetabolicsyndrome AT belmontefederica metabolomicsalivarysignatureofpediatricobesityrelatedliverdiseaseandmetabolicsyndrome AT bisognoantonella metabolomicsalivarysignatureofpediatricobesityrelatedliverdiseaseandmetabolicsyndrome AT pierriluca metabolomicsalivarysignatureofpediatricobesityrelatedliverdiseaseandmetabolicsyndrome AT colucciangelo metabolomicsalivarysignatureofpediatricobesityrelatedliverdiseaseandmetabolicsyndrome AT scalagiovanni metabolomicsalivarysignatureofpediatricobesityrelatedliverdiseaseandmetabolicsyndrome AT cavallopierpaolo metabolomicsalivarysignatureofpediatricobesityrelatedliverdiseaseandmetabolicsyndrome AT mandatoclaudia metabolomicsalivarysignatureofpediatricobesityrelatedliverdiseaseandmetabolicsyndrome AT dinuzziantonella metabolomicsalivarysignatureofpediatricobesityrelatedliverdiseaseandmetabolicsyndrome AT dimichelelaura metabolomicsalivarysignatureofpediatricobesityrelatedliverdiseaseandmetabolicsyndrome AT delliboviannapia metabolomicsalivarysignatureofpediatricobesityrelatedliverdiseaseandmetabolicsyndrome AT guercionuziosalvatore metabolomicsalivarysignatureofpediatricobesityrelatedliverdiseaseandmetabolicsyndrome AT vajropietro metabolomicsalivarysignatureofpediatricobesityrelatedliverdiseaseandmetabolicsyndrome |